RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4645
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1327100; Gene model (P.falciparum): PF3D7_1463900; Gene product: EF-hand calcium-binding domain-containing protein, putative (RON11)
Name tag: c-myc
Transgene
Transgene not Plasmodium: GFP (gfp-mu3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
Phenotype Asexual bloodstage; Sporozoite;
Last modified: 3 July 2019, 10:16
  *RMgm-4645
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 31247198
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
The mutant parasite was generated by
Name PI/ResearcherBantuchai S, Ishino T
Name Group/DepartmentDepartment of Molecular Parasitology, Graduate School of Medicine
Name InstituteEhime University
CityToon, Ehime
CountryJapan
Name of the mutant parasite
RMgm numberRMgm-4645
Principal namePbRON11-c-Myc
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stagePbRON11 tagged with c-Myc was confirmed to localize to the rhoptry neck region in merozoites.
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot different from wild type
SporozoitePbRON11 tagged with c-Myc was confirmed to localize to the rhoptry neck region in merozoites. PbRON11 tagged with c-Myc in sporozoites collected from salivary glands was localized to rhoptries, but not restricted to the neck portion.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
The mutant expresses a C-terminal cmyc-tagged version of RON11. In addition the mutant expresses GFP under the constitutive eef1a promoter.

Protein (function)
Rhoptry neck protein 11 (RON11) was first described as localized to the rhoptry neck in Toxoplasma tachyzoites (Beck et al., 2013). It has an architecture of seven transmembrane domains plus two putative calcium binding EF-hand domains, and is highly conserved in the Apicomplexa, suggesting an important role in rhoptry-mediated functions.

Phenotype
PbRON11 tagged with c-Myc was confirmed to localize to the rhoptry neck region in merozoites. PbRON11 tagged with c-Myc in sporozoites collected from salivary glands was localized to rhoptries, but not restricted to the neck portion.

RON11 is essential for blood stage development/multiplication (see RMgm-103, RMgm-190 for unsuccessful attempts to disrupt the apc3 gene). In a 'promoter-swap' mutant (RMgm-4644) the promoter of ron11 is replaced by an 'asexual blood stage’ promoter that is silent (or has a strongly reduced activity) in sporozoites (the promoter of msp9, PBANKA_1443300). This 'promoter swap' mutant showed the following phenotype: Normal blood stage development/multiplication. Normal sporozoite formation in oocysts. Normal release of sporozoites in hemocoel. Normal numbers of hemocoel sporozoites. However strongly reduced (120-200 fold) numbers of sporozoites in salivary glands. Hemocoel derived mutant sporozoites show strongly reduced infectivity in mice compared to wild type hemocoel derived sporozoites (10.000 fold reduction in liver load after intravenous injection of sporozoites). Evidence is presented for strongly reduced attachment of sporozoites to hepatocytes in vitro and reduced motility and adhesion of sporozoites. In contrast to PbTRAP, no PbRON11 signal was detected on the surface or the apical tip of activated control sporozoites, as visualized using anti-PbRON11N antibodies, indicating that PbRON11 remains inside the rhoptries during gliding.

Additional information
PbRON11 expression during sporozoite maturation in mosquitoes was also examined by using sporozoites collected from midguts, haemolymph, and salivary glands of infected Anopheles stephensi at day 23 post-feeding. Western blot analysis using anti-RON11 antibodies revealed that PbRON11 was detected migrating at approximately 100 kDa in all sporozoite samples, indicating that PbRON11 is synthesized early in sporozoite formation and the protein is present until after sporozoites invade salivary glands. This finding also suggests that PbRON11 is not cleaved during sporozoite maturation in mosquito bodies.
To examine PbRON11 localization, IFA was performed on P. berghei schizonts and sporozoites. PbRON11 was detected as a punctate pattern in mature schizonts. PbRON11 signal was distributed somewhat widely in the anterior part of sporozoites collected from midguts, and was concentrated in the apical region of sporozoites collected from haemolymph or salivary glands.. IEM was performed to refine localization of PbRON11. PbRON11 was demonstrated to localize to the neck portion of rhoptry of merozoites.
However, the signal for PbRON11 in sporozoites was not abundant by IEM using specific antibodies. Therefore, we generated transgenic parasites expressing PbRON11 fused with a c-Myc-tag at the C-terminus (RMgm-4645). PbRON11 tagged with c-Myc was confirmed to localize to the rhoptry neck region in merozoites. PbRON11 tagged with c-Myc in sporozoites collected from salivary glands was localized to rhoptries, but not restricted to the neck portion.

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1327100
Gene Model P. falciparum ortholog PF3D7_1463900
Gene productEF-hand calcium-binding domain-containing protein, putative
Gene product: Alternative nameRON11
Details of the genetic modification
Name of the tagc-myc
Details of taggingC-terminal
Additional remarks: tagging
Commercial source of tag-antibodies
Type of plasmid/construct(Linear) plasmid single cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate PbRON11-c-Myc expressing parasites, the pbron11 locus in PbWT-GFP parasites was replaced with an expression cassette in which RON11 is fused with a c-Myc tag at the C-terminus by single crossover homologous recombination. To generate the transgenic vector, the pL0033 vector, obtained from BEI Resource (USA), was modified as follows. The partial coding region of PbRON11, 3217-4936 bp from the first start codon, was amplified and inserted into the pL0033 vector using SacII and NcoI restriction enzymes. This transgenic vector was linearized by StyI enzyme prior to transfection.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mu3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modificationThe GFP gene (1 copy) has been inserted into the 230p locus (PBANKA_030600) by double cross-over integration.
Additional remarks selection procedureThis reporter mutant expressing GFP does not contain a drug-selectable marker. This mutant has been selected by FACS sorting after transfection based on GFP fluorescence.
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4